PURRO NORBERT,SMYTH MARK,GOLDMAN ERICK,WIRTH DAVID D.
申请号：
NZ70254813
公开号：
NZ702548A
申请日:
2013.06.03
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Described herein is the Bruton&rsquos tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, including crystalline forms, solvates and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions that include the Btk inhibitor, as well as methods of using the Btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
